- Story /
- Story /
A Novartis experimental drug in clinical trial aims to block liver cancer growth
- Story /
Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.
- Story /
A reversal in thinking about the reversibility of liver damage is changing the field of hepatology.
- Story /
These stories offer a glimpse into the lives of people touched by a new era of medicine.
- Story /
The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.
- Story /
Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.
- Story /
Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.
- Story /
Novartis researchers aim to quash inflammation to treat chronic disease.
- Statement /
Pagination
- ‹ Previous page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- …
- 264
- › Next page